Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.

HIV-positive patients on tenofovir hydroxyl fumarate (TDF)/emtricitabine have a lower risk of COVID-19 and hospitalization than those given other treatments. Our aim was to analyze the severity of COVID-19 in patients with chronic hepatitis B (CHB) on TDF or entecavir (ETV).

Detalles Bibliográficos
Autores: Mateos-Muñoz B, Buti M, Vázquez IF, Conde MH, Bernal-Monterde V, Díaz-Fontenla F, Morillas RM, García-Buey L, Badía E, Miquel M, Amador-Navarrete A, Rodríguez-Tajes S, Ramos-Merino L, Madejón A, García-Retortillo M, Arenas JI, Cabezas J, Santiago JMG, Fernández-Rodríguez C, Cordero P, Diago M, Mancebo A, Pardo A, Rodríguez M, Hoyas E, Moreno JJ, Turnes J, Simón MÁ, Marcos-Fosch C, Calleja JL, Bañares R, Lens S, Garcia-Samaniego J, Crespo J, Romero-Gomez M, Gea F, de Santiago ER, Moreno S, Albillos A
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Institut d'Investigació i Innovació Parc Taulí (I3PT)
Repositorio:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
OAI Identifier:oai:i3pt.fundanetsuite.com:p1885
Acceso en línea:https://i3pt.portalinvestigacion.com/publicaciones/1885
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147355793&doi=10.1007%2fs10620-022-07817-w&partnerID=40&md5=903f772b6a867aa67d4ec113f082c37d
Access Level:acceso abierto
Palabra clave:COVID-19, Entecavir, Hepatitis B, Tenofovir
id ES_ef6b2f06ae2fd58a8f2c5fd122c71bb4
oai_identifier_str oai:i3pt.fundanetsuite.com:p1885
network_acronym_str ES
network_name_str España
repository_id_str
spelling Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.Mateos-Muñoz BButi MVázquez IFConde MHBernal-Monterde VDíaz-Fontenla FMorillas RMGarcía-Buey LBadía EMiquel MAmador-Navarrete ARodríguez-Tajes SRamos-Merino LMadejón AGarcía-Retortillo MArenas JICabezas JSantiago JMGFernández-Rodríguez CCordero PDiago MMancebo APardo ARodríguez MHoyas EMoreno JJTurnes JSimón MÁMarcos-Fosch CCalleja JLBañares RLens SGarcia-Samaniego JCrespo JRomero-Gomez MGea Fde Santiago ERMoreno SAlbillos ACOVID-19, Entecavir, Hepatitis B, TenofovirHIV-positive patients on tenofovir hydroxyl fumarate (TDF)/emtricitabine have a lower risk of COVID-19 and hospitalization than those given other treatments. Our aim was to analyze the severity of COVID-19 in patients with chronic hepatitis B (CHB) on TDF or entecavir (ETV).SPRINGER2023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://i3pt.portalinvestigacion.com/publicaciones/1885https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147355793&doi=10.1007%2fs10620-022-07817-w&partnerID=40&md5=903f772b6a867aa67d4ec113f082c37dDIGESTIVE DISEASES AND SCIENCESISSN: 01632116ISSNe: 15732568reponame:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulíinstname:Institut d'Investigació i Innovació Parc Taulí (I3PT)Inglésinfo:eu-repo/semantics/openAccessoai:i3pt.fundanetsuite.com:p18852026-06-21T15:30:37Z
dc.title.none.fl_str_mv Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
title Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
spellingShingle Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
Mateos-Muñoz B
COVID-19, Entecavir, Hepatitis B, Tenofovir
title_short Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
title_full Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
title_fullStr Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
title_full_unstemmed Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
title_sort Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
dc.creator.none.fl_str_mv Mateos-Muñoz B
Buti M
Vázquez IF
Conde MH
Bernal-Monterde V
Díaz-Fontenla F
Morillas RM
García-Buey L
Badía E
Miquel M
Amador-Navarrete A
Rodríguez-Tajes S
Ramos-Merino L
Madejón A
García-Retortillo M
Arenas JI
Cabezas J
Santiago JMG
Fernández-Rodríguez C
Cordero P
Diago M
Mancebo A
Pardo A
Rodríguez M
Hoyas E
Moreno JJ
Turnes J
Simón MÁ
Marcos-Fosch C
Calleja JL
Bañares R
Lens S
Garcia-Samaniego J
Crespo J
Romero-Gomez M
Gea F
de Santiago ER
Moreno S
Albillos A
author Mateos-Muñoz B
author_facet Mateos-Muñoz B
Buti M
Vázquez IF
Conde MH
Bernal-Monterde V
Díaz-Fontenla F
Morillas RM
García-Buey L
Badía E
Miquel M
Amador-Navarrete A
Rodríguez-Tajes S
Ramos-Merino L
Madejón A
García-Retortillo M
Arenas JI
Cabezas J
Santiago JMG
Fernández-Rodríguez C
Cordero P
Diago M
Mancebo A
Pardo A
Rodríguez M
Hoyas E
Moreno JJ
Turnes J
Simón MÁ
Marcos-Fosch C
Calleja JL
Bañares R
Lens S
Garcia-Samaniego J
Crespo J
Romero-Gomez M
Gea F
de Santiago ER
Moreno S
Albillos A
author_role author
author2 Buti M
Vázquez IF
Conde MH
Bernal-Monterde V
Díaz-Fontenla F
Morillas RM
García-Buey L
Badía E
Miquel M
Amador-Navarrete A
Rodríguez-Tajes S
Ramos-Merino L
Madejón A
García-Retortillo M
Arenas JI
Cabezas J
Santiago JMG
Fernández-Rodríguez C
Cordero P
Diago M
Mancebo A
Pardo A
Rodríguez M
Hoyas E
Moreno JJ
Turnes J
Simón MÁ
Marcos-Fosch C
Calleja JL
Bañares R
Lens S
Garcia-Samaniego J
Crespo J
Romero-Gomez M
Gea F
de Santiago ER
Moreno S
Albillos A
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv COVID-19, Entecavir, Hepatitis B, Tenofovir
topic COVID-19, Entecavir, Hepatitis B, Tenofovir
description HIV-positive patients on tenofovir hydroxyl fumarate (TDF)/emtricitabine have a lower risk of COVID-19 and hospitalization than those given other treatments. Our aim was to analyze the severity of COVID-19 in patients with chronic hepatitis B (CHB) on TDF or entecavir (ETV).
publishDate 2023
dc.date.none.fl_str_mv 2023
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://i3pt.portalinvestigacion.com/publicaciones/1885
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147355793&doi=10.1007%2fs10620-022-07817-w&partnerID=40&md5=903f772b6a867aa67d4ec113f082c37d
url https://i3pt.portalinvestigacion.com/publicaciones/1885
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147355793&doi=10.1007%2fs10620-022-07817-w&partnerID=40&md5=903f772b6a867aa67d4ec113f082c37d
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv SPRINGER
publisher.none.fl_str_mv SPRINGER
dc.source.none.fl_str_mv DIGESTIVE DISEASES AND SCIENCES
ISSN: 01632116
ISSNe: 15732568
reponame:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
instname:Institut d'Investigació i Innovació Parc Taulí (I3PT)
instname_str Institut d'Investigació i Innovació Parc Taulí (I3PT)
reponame_str r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
collection r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869423861817147392
score 15.81155

Similares en LA Referencia